Prostate cancer cell heterogeneity and plasticity: Insights from studies of genetically-engineered mouse models

被引：7
|
作者：
Li, Weiping [1 ,2 ,3 ,4 ]
Shen, Michael M. [1 ,2 ,3 ,4 ]
机构：
[1] Columbia Univ, Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, Dept Med, New York, NY 10032 USA
[2] Columbia Univ, Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, Dept Genet & Dev, New York, NY 10032 USA
[3] Columbia Univ, Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, Dept Urol, New York, NY 10032 USA
[4] Columbia Univ, Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, Dept Syst Biol, New York, NY 10032 USA
来源：
SEMINARS IN CANCER BIOLOGY | 2022年 / 82卷
基金：
美国国家卫生研究院;
关键词：
Cell of origin; Cancer stem cell; Lineage plasticity; Castration-resistance; Genetically engineered mouse model; Tumor heterogeneity; TO-LUMINAL DIFFERENTIATION; EPITHELIAL STEM-CELL; ANDROGEN-RECEPTOR; BASAL-CELLS; NEUROENDOCRINE PHENOTYPE; LINEAGE PLASTICITY; PROGENITOR CELLS; OF-ORIGIN; RESISTANT; EXPRESSION;
D O I：
10.1016/j.semcancer.2021.06.016
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Although prostate adenocarcinoma lacks distinguishable histopathological subtypes, prostate cancer displays significant inter- and intratumor heterogeneity at the molecular level and with respect to disease prognosis and treatment response. In principle, understanding the basis for prostate cancer heterogeneity can help distinguish aggressive from indolent disease, and help overcome castration-resistance in advanced prostate cancer. In this review, we will discuss recent advances in understanding the cell types of origin, putative cancer stem cells, and tumor plasticity in prostate cancer, focusing on insights from studies of genetically engineered mouse models (GEMMs). We will also outline future directions for investigating tumor heterogeneity using mouse models of prostate cancer.
引用
收藏
页码：60 / 67
页数：8
相关论文
共 50 条
  • [1] Stem cells in genetically-engineered mouse models of prostate cancer
    Shibata, Maho
    Shen, Michael M.
    ENDOCRINE-RELATED CANCER, 2015, 22 (06) : T199 - T208
  • [2] Utility of genetically-engineered mouse models of cancer.
    Jacks, T
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9177S - 9177S
  • [3] Genetically-engineered mouse models of small cell lung cancer: the next generation
    Oser, Matthew G.
    Macpherson, David
    Oliver, Trudy G.
    Sage, Julien
    Park, Kwon-Sik
    ONCOGENE, 2024, 43 (07) : 457 - 469
  • [4] Genetically-engineered mouse models of small cell lung cancer: the next generation
    Matthew G. Oser
    David MacPherson
    Trudy G. Oliver
    Julien Sage
    Kwon-Sik Park
    Oncogene, 2024, 43 : 457 - 469
  • [5] Genetically engineered mouse models of prostate cancer
    Parisotto, Maxime
    Metzger, Daniel
    MOLECULAR ONCOLOGY, 2013, 7 (02) : 190 - 205
  • [6] Genetically engineered mouse models of prostate cancer
    Nawijn, Martijn C.
    Bergman, Andreas M.
    van der Poel, Henk G.
    EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (08) : 566 - 575
  • [7] Genetically-engineered mouse models of cerebral amyloidosis
    Jucker, M
    JOURNAL OF NEUROCHEMISTRY, 2005, 94 : 80 - 80
  • [8] Characterization of amelanotic melanomas from genetically-engineered mouse models
    Florell, S. R.
    Clayton, F.
    Rahman, H.
    Holmen, S.
    Burd, C.
    Grossman, D.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (05) : S139 - S139
  • [9] Genetically-engineered mouse models for pancreatic cancer: Advances and current limitations
    Ijichi, Hideaki
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2011, 2 (05): : 195 - 202
  • [10] Genetically engineered mouse models of prostate cancer: from man to mouse and back
    Uemura, Hirotsugu
    De Velasco, Marco A.
    CANCER SCIENCE, 2018, 109 : 682 - 682
12345